Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075853

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075853

Diabetic Foot Ulcers Treatment Market, By Product, By Ulcer Type, By End User, By Geography

PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Diabetic Foot Ulcers Treatment Market is estimated to be valued at USD 10.36 Bn in 2026 and is expected to reach USD 20.70 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 10.36 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.40% 2033 Value Projection: USD 20.70 Bn

Diabetic foot ulcer is a common condition in diabetic patients, which may lead to amputation of the leg. People who rely on insulin for the treatment of diabetes are at high risk of developing a foot ulcer. Moreover, people suffering from diabetes-related kidney, eye, and heart disease and obesity can also suffer from diabetic foot ulcers. The risk of the disease is high in those consuming alcohol and tobacco. The common initial symptoms of diabetic foot ulcer include unusual swelling, redness, irritation, and stenches on one or both feet. Diabetic foot ulcer treatment, usually include control of blood sugar, removal of dead tissue, wound dressings, and negative pressure therapy.

Market Dynamics

Key players operating in the global diabetic foot ulcer treatment market are focusing on adoption of growth strategies such as product launches and regulatory approvals, which are expected to drive the market growth during the forecast period. For instance, in November 2019, Pergamum AB, a subsidiary of Promore Pharma AB, a Sweden-based biopharmaceutical company, received a patent in the U.S. for the pharmaceutical formulation of the product candidate PXL01 used for the treatment of diabetic foot ulcers. Moreover, in December 2019, Orpyx Medical Technologies Inc., a medical device company that designs and develops sensory insole systems for the treatment of diabetic foot ulcers, launched Orpyx SI Sensory Insoles with for the prevention of diabetic foot ulcers and neuropathy-related ulcers. Furthermore, in December 2017, SANUWAVE Health Inc., received the US approval for marketing of the Dermapace system, the indicated to treat diabetic foot ulcer.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for global diabetic foot ulcer treatment market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global diabetic foot ulcer treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include 3M Healthcare, B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, and Molnlycke Health Care AB
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global diabetic foot ulcer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic foot ulcer treatment market

Detailed Segmentation:

  • Global Diabetic Foot Ulcer Treatment Market, By Product (Revenue, USD Bn, 2021 - 2033)
  • Advance Wound Dressings
  • Skin Substitutes
  • Growth Factors
  • Negative Pressure Wound Therapy Devices
  • Other Devices
  • Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type (Revenue, USD Bn, 2021 - 2033)
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers
  • Global Diabetic Foot Ulcer Treatment Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Long Term Care Centers
  • Ambulatory Surgical Center
  • Global Diabetic Foot Ulcer Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • 3M Healthcare*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
  • Smith & Nephew, Inc.
  • Organogenesis, Inc.
  • Derma Sciences Inc.
  • Sigvaris Inc.
  • Acelity L.P. Inc.
  • Osiris
  • Molnlycke Health Care AB

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1357

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Ulcer Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Diabetic Foot Ulcers Treatment Market, By Product, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Advance Wound Dressings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Negative Pressure Wound Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Other Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

5. Global Diabetic Foot Ulcers Treatment Market, By Ulcer Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Neuropathic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Neuro-ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

6. Global Diabetic Foot Ulcers Treatment Market, By End User, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Long Term Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

7. Global Diabetic Foot Ulcers Treatment Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • 3M Healthcare*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Smith & Nephew, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Organogenesis, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Derma Sciences Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sigvaris Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Acelity L.P. Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Osiris
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Molnlycke Health Care AB
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Alkem Laboratories Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Healthium Medtech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Kerecis
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Podimetrics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Carmell Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Paracrine, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • VIVEX Biologics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • PolarityTE, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!